ReviewHeliyon2022
How generalisable are material extrusion additive manufacturing parameter optimisation studies? A systematic review.
Review in Heliyon, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Impact of temperature and humidity on the structural and biocompatibility of 3D-Printed PLA scaffolds for bone regeneration.Scientific reports · 2026Article
- Article
- The production and materials of mouthguards: Conventional vs additive manufacturing - A systematic review.Heliyon · 2024Article
- Three-Dimensional Microfibrous Scaffold with Aligned Topography Produced via a Combination of Melt-Extrusion Additive Manufacturing and Porogen Leaching for In Vitro Skeletal Muscle Modeling.Bioengineering (Basel, Switzerland) · 2024Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Goal: Material extrusion additive manufacturing, is a relatively inexpensive and popular manufacturing technique that can be used to fabricate complex 3D geometries at low cost. However, parts produced by this process are often characterised by poor quality, particularly with regards to dimensional and geometrical accuracy. This review provides a comprehensive analysis of experimental studies conducted over the past 25 years that have aimed to improve these quality variables via printing parameter optimisation. Methods: An initial non systematic scoping study coupled with a subsequent scientific systematic literature review protocol to identify experimental studies on dimensional quality in material extrusion additive manufacturing was conducted. 127 individual studies are identified and analysed. Results: The authors critically analysed the relevant and salient studies (127) by evaluating which machines; materials; sample sizes; artefact designs; and most importantly what printing parameters have been used in the experimental investigations. A total of (79) machine variations were used; ABS and PLA made up (43%) and (36%) of materials investigated respectively; (84%) of studies had sample sizes of less than (40); and artefact dimensions ranged from (10-270 mm) (1-240 mm), and (3.5-220 mm) in the X, Y, and Z axes respectively. In many cases, the relationships between printing parameters (independent variables) and dimensional qualities (dependent variables) were found to be uncertain or even contradictory between studies. Conclusions: A wide range of studies have sought to optimise parameters (e.g., Nozzle gap height, print head velocity, filament volumetric velocity) to address dimensional quality issues in ME AM. However, the authors have demonstrated that a lack of agreement among studies limits the generalisability of these parameter optimisation findings. More recent studies have considered the local dimensional variance of deposited single strands. This offers greater potential to understand the underlying causes of component defects and inaccuracy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.